A pilot phase II randomized, cross-over, double-blinded, controlled efficacy study of octreotide versus hyoscine hydrobromide for control of noisy breathing at the end-of-life

Secondary title: 
T2 - Journal of pain & palliative care pharmacotherapy
Short title: 
A pilot phase II randomized, cross-over, double-blinded, controlled efficacy study of octreotide versus hyoscine hydrobromide for control of noisy breathing at the end-of-life
Authors: 
Clark, K.
Currow, D. C.
Agar, M.
Fazekas, B. S.
Abernethy, A. P.
Start page: 
131-8
Annotations: 
Type B, Priority 5
Year: 
2008
Accession number: 
CN-00665013
Database: 
CENTRAL Issue 4 2014
Number: 
M1 - 2
ID: 
597
Notes: 
N1 - Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Key words: 
Cross-Over Studies
Double-Blind Method
Family [psychology]
Gastrointestinal Agents [administration & dosage] [therapeutic use]
Muscarinic Antagonists [administration & dosage] [therapeutic use]
Neoplasms [physiopathology]
Octreotide [administration & dosage] [therapeutic use]
Palliative Care [methods]
Pilot Projects
Respiratory Sounds [drug effects]
Respiratory System [drug effects] [secretion]
Scopolamine Hydrobromide [administration & dosage] [therapeutic use]
Terminally Ill
Aged[checkword]
Aged, 80 and over[checkword]
Female[checkword]
Humans[checkword]
Male[checkword]
Middle Aged[checkword]
Sr-sympt
Types of evidence: 
Type B
Priorities of Care: 
Priority 5: Plan and do